Our study identified six hub genes (RRM2, TOP2A, CCNB1, CDK1, BIRC5 and PBK) that are significantly associated with HCC and may serve as potential prognostic biomarkers or therapeutic targets in HCC. This evidence concerns the gene RRM2 and hepatocellular carcinoma.